Gilead eyes trials of remdesivir combo with other drugs

In India, Gilead has signed a voluntary licensing agreement with four firms--Cipla, Hetero Drugs, Jubilant Life Sciences and Mylan.Gilead will transfer the technology to its partners, and the sale will be royalty-free until an alternative drug for covid is found